Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. - Test2 - elhamkhani - TriplyDB

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

http://www.wikidata.org/entity/Q35629499

about

Autism and brain development Emerging pharmacotherapies for neurodevelopmental disorders Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice Epigenetic principles and mechanisms underlying nervous system functions in health and disease Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency Developmental Dynamics of Rett Syndrome Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target MECP2 disorders: from the clinic to mice and back MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?Cytosine modifications in neurodevelopment and diseases 5-Hydroxymethylcytosine: A new player in brain disorders?Cellular and synaptic network defects in autism GABAergic signaling as therapeutic target for autism spectrum disorders Therapeutic approaches for shankopathies Rett Syndrome: Reaching for Clinical Trials A review of Rett syndrome (RTT) with induced pluripotent stem cells MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells Unexpected cellular players in Rett syndrome pathology The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression Beyond Widespread Mecp2 Deletions to Model Rett Syndrome: Conditional Spatio-Temporal Knockout, Single-Point Mutations and Transgenic Rescue Mice Preclinical research in Rett syndrome: setting the foundation for translational success.Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome.Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress High levels of MeCP2 depress MHC class I expression in neuronal cells.MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy Unconventional transcriptional response to environmental enrichment in a mouse model of Rett syndrome.Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study.Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.The role of MeCP2 in brain development and neurodevelopmental disorders Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes.Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants

P2860

Q22252316-C45477EC-7C26-41DC-8174-BA80A5805C12 Q24619170-63081068-5AF7-45A9-809E-80548C75D9D8 Q24633450-2AC005ED-C106-438D-8550-F21CD930625E Q24633673-14A172F3-08D5-4EBC-ADEA-C81AB549F8FD Q24651541-44DB2411-AD57-40E2-8DB1-6D62005A1EDF Q24657549-FC00A87D-2ECD-4E3B-A7DD-746380BA2882 Q24670122-217AF24E-353D-48A7-96B5-F13AB6DC2FDB Q24677959-57912E26-F58C-4111-ACA5-FA3082CBABBD Q26768284-F5BA0C3A-10C7-4DF6-8B65-28587D623B4C Q26796321-2FA49405-50CA-4C51-B7E7-C03ACE0705FF Q26798948-749D023D-E965-4082-A5DE-D1F340765D04 Q26799760-55A53805-1717-44A1-9011-23B770FEA6DD Q26824983-A7F25BDF-0743-4C5B-9FEA-84F02D16AF79 Q26852087-114FAF16-6D6F-4658-B27A-6EF15BF2C012 Q26853292-73F516AD-C521-4CE5-A030-A4B7E79B04B9 Q26864843-3D4554F6-06F6-44EA-8241-2C4B107F9171 Q27013583-7AAA8970-DDB5-4E90-8E97-DBB27DDA5CDC Q27024976-B3EF4E67-FD8A-4426-B3B6-EB962BF6CFB8 Q27337778-3C8065F0-A62F-4121-9CDD-982D94E843CA Q28072303-013DC347-27E2-47DB-BDC3-CB002D5B6684 Q28507266-4019482F-7859-4C75-881F-AD3C9FF1411F Q28743688-97FC17FE-DCD6-423F-ACD1-C94BBD51915C Q28909812-0E94FD78-0A8F-44A4-8727-AF25817ABF96 Q29619964-1864783E-A067-4B9A-8E66-B01A6212C256 Q30299929-C66402C9-4E11-486F-B205-919C9B4B9885 Q30355076-52166168-4E3D-4448-946D-CCF10D2E38C6 Q30357465-26AE423D-1628-45B6-9993-BD2DDE111DE1 Q30450914-B1E2C008-C759-4D9B-8D26-D0401B307265 Q30527828-1624113B-9DA4-4297-A2D3-7D9E02D33BAE Q30575472-C11C7EBA-EE10-4113-830B-99DA4CF4FB22 Q30843318-59522929-3F19-48E7-ABC2-6ABDF1EFEBB9 Q33312371-5B6E140E-56D8-48C2-9C69-02F2D5C9AECF Q33497321-8F0BF670-0BA1-4359-A774-5B247CE8794F Q33633998-DAC0E95A-A1D0-4835-B5BD-5EA97C1CA5FA Q33702137-1684AED0-0728-47FD-A761-68E126BBC7B2 Q33740090-7ADE4DBF-FB2B-4A66-AC9F-981C4A01FD75 Q33762214-CEB84040-601B-41D7-896F-6BBBDF6D9579 Q33836894-DCB303D4-B1C4-49FF-9902-F0A32B8837CF Q33919627-61E9B4A2-EF89-48C8-AD62-A1D780AAB80B Q34086410-EFD0FB47-A169-4177-A2F9-D800CEE26B4E

P2860

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

http://www.wikidata.org/entity/Q35629499

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@ast

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@en

type

label

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@ast

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@en

prefLabel

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@ast

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@en

P1433

Q35629499-4266F9F7-C9BD-4159-A617-5E49CC581D48

P1476

Q35629499-F14AA74E-5A9C-4A5B-9A08-B1B0A10B2DCB

P2093

Q35629499-52E47650-5EFE-41A9-BA1C-361882F70D07

Q35629499-819E5FAA-F28E-4874-A1E7-3400ED66FE53

Q35629499-C557C273-7629-46ED-B25E-C7D962C42704

P2860

Q35629499-0305E5B0-0004-4B92-8EFC-69B8C3402235

Q35629499-0496FBE4-9735-4BFA-B843-0AD7CAABF3E2

Q35629499-082A0DE6-D25D-4770-AE65-5C63A1EDB612

Q35629499-17BCC31A-2739-46FA-ABCD-0495085B4B84

Q35629499-2F2F9E7B-1C57-433C-BEB8-1004EB24C963

Q35629499-3D90B584-F682-4B07-BE7A-8F9748190FB8

Q35629499-4103625B-0300-418F-B0BF-7C3D2AAE45A9

Q35629499-41830238-95C2-4E4A-8F3B-B0F28A8186B8

Q35629499-41D63B7A-3558-46FD-8A08-D4812FC68360

Q35629499-500D4B75-4C52-4A0D-AF78-E329F4319CA5

P304

Q35629499-655DED80-2CCC-4B2E-B5FC-11B1682CD12C

P31

Q35629499-C4212981-622B-43EC-A568-855A2A4B49BE

P356

Q35629499-F3CCEA9C-04FF-47A2-9E4C-D3FF2547558F

P407

Q35629499-4DD3E4BA-4ED6-41A4-B436-D25D86121CC8

P433

Q35629499-CD2AA37F-8A46-4A0E-9CDF-352C5BBEF835

P478

Q35629499-067621C4-3A28-482A-A2AF-14CDFEAE1383

P50

Q35629499-826BAA98-8995-4315-9C69-91D6AD7ADAB2

P577

Q35629499-E4176880-DC43-4A22-96AD-17A3C7A8CBD3

P5875

Q35629499-8C56097B-26C5-4B63-AE39-A105DA08E9EF

P698

Q35629499-894E43BA-92EF-4B47-97B2-408A7A498AA1

P932

Q35629499-B8030AE7-ACC0-40F1-A08E-6CD8ACD521F5

P356

PNAS.0610593104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

@en

P2093

Caroline Beard

http://www.w3.org/2001/XMLSchema#string

Emanuela Giacometti

http://www.w3.org/2001/XMLSchema#string

Sandra Luikenhuis

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome

Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice

Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations

Efficient selection for high-expression transfectants with a novel eukaryotic vector

Generalized lacZ expression with the ROSA26 Cre reporter strain

Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA

Genomic DNA methylation: the mark and its mediators

A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome

P304

1931-1936

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0610593104

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Rudolf Jaenisch

P577

2007-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6536271

http://www.w3.org/2001/XMLSchema#string

P698

17267601

http://www.w3.org/2001/XMLSchema#string

P932

1794312

http://www.w3.org/2001/XMLSchema#string